1,571 Shares in Portola Pharmaceuticals Inc (NASDAQ:PTLA) Acquired by Tower Research Capital LLC TRC
Tower Research Capital LLC TRC purchased a new position in shares of Portola Pharmaceuticals Inc (NASDAQ:PTLA) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 1,571 shares of the biopharmaceutical company’s stock, valued at approximately $42,000.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Next Capital Management LLC acquired a new position in shares of Portola Pharmaceuticals during the second quarter worth $27,000. Point72 Hong Kong Ltd acquired a new stake in Portola Pharmaceuticals in the second quarter valued at $31,000. Cornerstone Advisors Inc. raised its stake in Portola Pharmaceuticals by 34.6% in the third quarte ...